Malaria vaccines: Evaluation and implementation
- 30 September 2005
- journal article
- research article
- Published by Elsevier in Acta Tropica
- Vol. 95 (3), 298-304
- https://doi.org/10.1016/j.actatropica.2005.04.017
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trialThe Lancet, 2004
- TESTING VACCINES IN HUMAN EXPERIMENTAL MALARIA: STATISTICAL ANALYSIS OF PARASITEMIA MEASURED BY A QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTIONThe American Journal of Tropical Medicine and Hygiene, 2004
- Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21Vaccine, 2002
- Malaria Vaccine TrialsPublished by S. Karger AG ,2002
- Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trialThe Lancet, 2001
- Transmission blocking malaria vaccinesVaccine, 2001
- Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines.The American Journal of Tropical Medicine and Hygiene, 1997
- Mortality and morbidity from malaria after stopping malaria chemoprophylaxisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityVaccine, 1992
- Immunization of man against sporozite-induced falciparum malariaThe American Journal of the Medical Sciences, 1973